234 related articles for article (PubMed ID: 24229034)
1. Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats.
Yabanoglu H; Basaran O; Aydogan C; Azap OK; Karakayali F; Moray G
Int Surg; 2013; 98(4):416-23. PubMed ID: 24229034
[TBL] [Abstract][Full Text] [Related]
2. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
[TBL] [Abstract][Full Text] [Related]
3. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds.
Acar A; Uygur F; Diktaş H; Evinç R; Ulkür E; Oncül O; Görenek L
Burns; 2011 Aug; 37(5):882-5. PubMed ID: 21354707
[TBL] [Abstract][Full Text] [Related]
4. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds.
Ulkür E; Oncul O; Karagoz H; Yeniz E; Celiköz B
Burns; 2005 Nov; 31(7):874-7. PubMed ID: 16011879
[TBL] [Abstract][Full Text] [Related]
5. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing.
Fraser JF; Bodman J; Sturgess R; Faoagali J; Kimble RM
Burns; 2004 Feb; 30(1):35-41. PubMed ID: 14693084
[TBL] [Abstract][Full Text] [Related]
6. Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound.
Snelling CF; Roberts FJ; Germann E; Gillespie K; Coderre S; Henry D
Burns Incl Therm Inj; 1988 Apr; 14(2):91-100. PubMed ID: 3134114
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of silver sulfadiazine action on burn wound infections.
Fox CL; Modak SM
Antimicrob Agents Chemother; 1974 Jun; 5(6):582-8. PubMed ID: 15825409
[TBL] [Abstract][Full Text] [Related]
8. Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.
Modak S; Fox CL
J Trauma; 1985 Jan; 25(1):27-31. PubMed ID: 3917512
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 1% silver sulfadiazine with and without 1% chlorhexidine digluconate for topical antibacterial effect in the burnt infected rat.
Snelling CF; Roberts FJ
J Burn Care Rehabil; 1988; 9(1):35-40. PubMed ID: 3128553
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
[TBL] [Abstract][Full Text] [Related]
11. Antiseptics for burns.
Norman G; Christie J; Liu Z; Westby MJ; Jefferies JM; Hudson T; Edwards J; Mohapatra DP; Hassan IA; Dumville JC
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011821. PubMed ID: 28700086
[TBL] [Abstract][Full Text] [Related]
12. Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds.
Modak SM; Sampath L; Fox CL
J Burn Care Rehabil; 1988; 9(4):359-63. PubMed ID: 3146573
[TBL] [Abstract][Full Text] [Related]
13. Comparison of silver sulfadiazine 1% with chlorhexidine digluconate 0.2% to silver sulfadiazine 1% alone in the prophylactic topical antibacterial treatment of burns.
Snelling CF; Inman RJ; Germann E; Boyle JC; Foley B; Kester DA; Fitzpatrick DJ; Warren RJ; Courtemanche AD
J Burn Care Rehabil; 1991; 12(1):13-8. PubMed ID: 2022674
[TBL] [Abstract][Full Text] [Related]
14. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
Modak SM; Fox CL
Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of silver-loaded nanofiber dressings in Candida albicans-contaminated full-skin thickness rat burn wounds.
Ciloglu NS; Mert AI; Doğan Z; Demir A; Cevan S; Aksaray S; Tercan M
J Burn Care Res; 2014; 35(5):e317-20. PubMed ID: 25118002
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of four topical treatment methods in a rat model of superficial partial-thickness burn injury: the advantages of combining zinc-hyaluronan gel with silver foam dressing.
Csenkey A; Hargitai E; Pakai E; Kajtar B; Vida L; Lorincz A; Gergics M; Vajda P; Jozsa G; Garami A
Injury; 2022 Dec; 53(12):3912-3919. PubMed ID: 36216616
[TBL] [Abstract][Full Text] [Related]
17. Comparison between Alpha and silver sulfadiazine ointments in treatment of Pseudomonas infections in 3rd degree burns.
Hosseini SV; Tanideh N; Kohanteb J; Ghodrati Z; Mehrabani D; Yarmohammadi H
Int J Surg; 2007 Feb; 5(1):23-6. PubMed ID: 17386910
[TBL] [Abstract][Full Text] [Related]
18. Effects of three different topical antibacterial dressings on Acinetobacter baumannii-contaminated full-thickness burns in rats.
Uygur F; Oncül O; Evinç R; Diktas H; Acar A; Ulkür E
Burns; 2009 Mar; 35(2):270-3. PubMed ID: 18789593
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the antibacterial effect of silver sulfadiazine 1%, mupirocin 2%, Acticoat and octenidine dihydrochloride in a full-thickness rat burn model contaminated with multi drug resistant Acinetobacter baumannii.
Selçuk CT; Durgun M; Ozalp B; Tekin A; Tekin R; Akçay C; Alabalık U
Burns; 2012 Dec; 38(8):1204-9. PubMed ID: 22688192
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns.
Muangman P; Pundee C; Opasanon S; Muangman S
Int Wound J; 2010 Aug; 7(4):271-6. PubMed ID: 20528992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
